Clinical and pathological response to pre-operative crizotinib in a patient with ALK-translocated NSCLC

Journal Title: Journal of Cancer Research & Therapy - Year 2016, Vol 4, Issue 6

Abstract

A 65-year-old non-smoker female was diagnosed with lung adenocarcinoma clinically staged as IV M1a because of bilateral pulmonary lesions. After a differential response to chemotherapy, further analyses allowed us to re-stage the tumor as a synchronous bilateral local disease with unilateral ALK (Anaplastic lymphoma kinase) rearrangement. Combined treatment with chemotherapy, crizotinib and surgery, with clinical and pathological tumor-response to pre-operative crizotinib, obtained complete tumors remission, and the patient is still disease free after 11 months since the last tumor resection. As far as we know this is the first report of a clinical and pathological regression of an early-stage ALK-rearranged NSCLC treated with neo-adjuvant crizotinib. This report supports further studies to assess activity and efficacy of ALK–inhibitors in neoadjuvant setting.

Authors and Affiliations

Catania C, Barberis M, Petrella F, Solli P, DePas TM, Perrone G, Gianluca S, Noberasco C, Passaro A, Rocco EG, deMarinis F

Keywords

Related Articles

Characterizing tobacco use in an American cancer center’s catchment area can help direct future research priorities

Purpose: American cancer centers supported by the National Cancer Institute (NCI) must ensure that their research addresses the cancer relevant needs and risks of members of their catchment area. In 2016, the NCI support...

Calcification of peritoneum and peritoneal fluid perfusion malfunction in carcinomatosis of serous membranes of peritoneal cavity

The article describes the peritoneal calcification in peritoneal carcinomatosis, as well as its possible role in the development of carcinomatosis within the frames of the authors’ alternative theory. The analysis of the...

The prevention and treatment of peritoneal carcinomatosis from gastric cancer: A 2013 update

Gastric cancer is the fourth most common cancer and the second leading cause of cancer death in the world. Penetration of the gastric serosa and lymphatic spread are the two most important factors affecting prognosis in...

Anatomic categorization of gastrointestinal malignancies using haematoxylin and eosin stains: A 10-year retrospective histopathological study at the Korle-Bu Teaching Hospital Accra

Background: Data on gastrointestinal (GI) malignancies in Ghana are relatively uncommon and are mostly on colorectal cancers. The aim of this descriptive study was to categorize gastrointestinal tract malignancies accord...

The positive sentinel lymph node biopsy- can we predict which patients will benefit from further surgery?

Introduction: Although sentinel lymph node biopsy (SLNB) is the gold standard for clinical and radiological negative axillae in breast cancer, the subsequent management of positive nodes is currently under scrutiny with...

Download PDF file
  • EP ID EP544809
  • DOI 10.14312/2052-4994.2016-10
  • Views 45
  • Downloads 0

How To Cite

Catania C, Barberis M, Petrella F, Solli P, DePas TM, Perrone G, Gianluca S, Noberasco C, Passaro A, Rocco EG, deMarinis F (2016). Clinical and pathological response to pre-operative crizotinib in a patient with ALK-translocated NSCLC. Journal of Cancer Research & Therapy, 4(6), 55-58. https://europub.co.uk/articles/-A-544809